Asia's three medical tourism giants each treat millions of international patients — and each is genuinely the best choice for certain cases and the wrong choice for others. We coordinate treatment in China, so you know our vantage point; but a patient who picks the wrong destination becomes nobody's success story. Here's the comparison we'd give a friend.
The Short Version
- India — the lowest absolute prices in the world for major surgery. Best for budget-critical cardiac surgery and transplants, with deep English-language infrastructure.
- Thailand — the most polished hospitality. Best for cosmetic surgery, dental work, and elective procedures combined with recovery in a resort setting.
- China — the technology and volume leader. Best for advanced oncology (CAR-T, proton/heavy-ion therapy), neurosurgery, complex cases, and comprehensive health screening; 30–50% cheaper than Thailand on most major procedures.
Cost Comparison: Real 2026 Examples
| Procedure | US | India | Thailand | China |
|---|---|---|---|---|
| Heart bypass (CABG) | $70,000–200,000 | $7,000–10,000 | $20,000–30,000 | $12,000–25,000 |
| Hip/knee replacement | $40,000–60,000 | $7,000–12,000 | $15,000–20,000 | $12,000–21,000 |
| CAR-T cell therapy | $400,000+ | Limited availability | Not widely available | $120,000–150,000 |
| Executive health screening | $3,000–5,000 | $300–600 | $500–1,200 | $400–1,500 |
*Representative package ranges compiled from published 2026 medical-tourism pricing; individual quotes vary by hospital and case complexity.
Where Each Country Genuinely Wins
India: Unbeatable on Price
For a patient whose constraint is purely budget, India is hard to argue against — cardiac surgery at $7,000–10,000 is roughly half of anywhere else in Asia. English is the working language of Indian medicine, the e-Medical visa covers 160+ nationalities and processes online in days, and hospitals like Apollo and Fortis have decades of international patient experience. The trade-offs: infrastructure quality varies sharply between flagship private hospitals and everything else, and for cutting-edge therapies (cell therapy, advanced radiotherapy) availability lags.
Thailand: The Hospitality Champion
Bangkok's private international hospitals pioneered treating hospitals like hotels, and it shows — seamless English service, airport lounges, and recovery suites that feel like resorts. For cosmetic surgery, dental restoration, and elective procedures where the experience matters as much as the medicine, Thailand earns its reputation. The trade-off is price: Thailand now costs 30–50% more than China and 2–3x India for comparable major surgery, and for complex oncology or neurosurgery its case volumes don't match the giants.
China: Technology and Volume
China's case is built on two things no neighbor matches. First, surgical volume: centers like Beijing Tiantan (12,000+ neurosurgical procedures a year — see our brain tumor guide) and Fuwai (one of the world's largest cardiac programs — see the heart surgery price guide) operate at scales that concentrate rare-case experience. Second, advanced therapy access: China is one of very few countries offering both CAR-T cell therapy and proton/heavy-ion radiotherapy at a fraction of US pricing, with more CAR-T clinical trials than any other country. Historic weaknesses — English support and visa friction — have narrowed sharply: designated international medical service hospitals now run English-speaking international departments, and 30-day visa-free entry covers roughly 50 nationalities through 2026.
Decision Framework
| Your Situation | Strongest Choice |
|---|---|
| Budget is the binding constraint; standard major surgery | India |
| Cosmetic/dental work + vacation-style recovery | Thailand |
| Advanced cancer therapy (CAR-T, proton/heavy-ion) | China |
| Complex neurosurgery or high-risk "second opinion" cases | China |
| Cardiac surgery, mid-range budget, want top-tier volume | China or India |
| Comprehensive same-day health screening | China |